238 related articles for article (PubMed ID: 19258950)
1. Recent developments on the significance and pathogenesis of lymph node involvement in ovarian serous tumors of low malignant potential (borderline tumors).
Fadare O
Int J Gynecol Cancer; 2009 Jan; 19(1):103-8. PubMed ID: 19258950
[TBL] [Abstract][Full Text] [Related]
2. Lymph node involvement in ovarian serous tumors of low malignant potential (borderline tumors): pathology, prognosis, and proposed classification.
McKenney JK; Balzer BL; Longacre TA
Am J Surg Pathol; 2006 May; 30(5):614-24. PubMed ID: 16699316
[TBL] [Abstract][Full Text] [Related]
3. A comparative analysis of lymphatic vessel density in ovarian serous tumors of low malignant potential (borderline tumors) with and without lymph node involvement.
Fadare O; Orejudos MP; Jain R; Mariappan MR; Hecht JL; Renshaw IL; Hileeto D; Wang SA; Ghofrani M; Liang SX
Int J Gynecol Pathol; 2008 Oct; 27(4):483-90. PubMed ID: 18753975
[TBL] [Abstract][Full Text] [Related]
4. Ovarian serous tumors of low malignant potential with nodal low-grade serous carcinoma.
Djordjevic B; Malpica A
Am J Surg Pathol; 2012 Jul; 36(7):955-63. PubMed ID: 22613998
[TBL] [Abstract][Full Text] [Related]
5. Lymph node metastasis in ovarian cancer: difference between serous and non-serous primary tumors.
Takeshima N; Hirai Y; Umayahara K; Fujiwara K; Takizawa K; Hasumi K
Gynecol Oncol; 2005 Nov; 99(2):427-31. PubMed ID: 16112718
[TBL] [Abstract][Full Text] [Related]
6. Serous carcinoma of the ovary and peritoneum with metastases to the breast and axillary lymph nodes: a potential pitfall.
Recine MA; Deavers MT; Middleton LP; Silva EG; Malpica A
Am J Surg Pathol; 2004 Dec; 28(12):1646-51. PubMed ID: 15577686
[TBL] [Abstract][Full Text] [Related]
7. Metastatic serous borderline ovarian tumor in an internal mammary lymph node: a case report and review of the literature.
Chamberlin MD; Eltabbakh GH; Mount SL; Leavitt BJ
Gynecol Oncol; 2001 Jul; 82(1):212-5. PubMed ID: 11426990
[TBL] [Abstract][Full Text] [Related]
8. Possible metaplastic origin of lymph node "metastases" in serous ovarian tumor of low malignant potential (borderline serous tumor).
Kadar N; Krumerman M
Gynecol Oncol; 1995 Dec; 59(3):394-7. PubMed ID: 8522262
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of lymph node involvement in ovarian serous borderline tumors.
Lesieur B; Kane A; Duvillard P; Gouy S; Pautier P; Lhommé C; Morice P; Uzan C
Am J Obstet Gynecol; 2011 May; 204(5):438.e1-7. PubMed ID: 21349494
[TBL] [Abstract][Full Text] [Related]
10. Patterns of stromal invasion in ovarian serous tumors of low malignant potential (borderline tumors): a reevaluation of the concept of stromal microinvasion.
McKenney JK; Balzer BL; Longacre TA
Am J Surg Pathol; 2006 Oct; 30(10):1209-21. PubMed ID: 17001150
[TBL] [Abstract][Full Text] [Related]
11. Lymph Node Involvement Pattern and Survival Differences of FIGO IIIC and FIGO IIIA1 Ovarian Cancer Patients After Primary Complete Tumor Debulking Surgery: A 10-Year Retrospective Analysis of the Tumor Bank Ovarian Cancer Network.
Gasimli K; Braicu EI; Nassir M; Richter R; Babayeva A; Chekerov R; Darb-Esfahani S; Sehouli J; Muallem MZ
Ann Surg Oncol; 2016 Apr; 23(4):1279-86. PubMed ID: 26832880
[TBL] [Abstract][Full Text] [Related]
12. Ovarian serous borderline tumors: a critical review of the literature with emphasis on prognostic indicators.
Seidman JD; Kurman RJ
Hum Pathol; 2000 May; 31(5):539-57. PubMed ID: 10836293
[TBL] [Abstract][Full Text] [Related]
13. Stage IIIC ovarian/peritoneal serous carcinoma: a heterogeneous group of patients with different prognoses.
Bakkar R; Gershenson D; Fox P; Vu K; Zenali M; Silva E
Int J Gynecol Pathol; 2014 May; 33(3):302-8. PubMed ID: 24681743
[TBL] [Abstract][Full Text] [Related]
14. Assessing the risk of pelvic and para-aortic nodal involvement in apparent early-stage ovarian cancer: A predictors- and nomogram-based analyses.
Bogani G; Tagliabue E; Ditto A; Signorelli M; Martinelli F; Casarin J; Chiappa V; Dondi G; Leone Roberti Maggiore U; Scaffa C; Borghi C; Montanelli L; Lorusso D; Raspagliesi F
Gynecol Oncol; 2017 Oct; 147(1):61-65. PubMed ID: 28779965
[TBL] [Abstract][Full Text] [Related]
15. Lymph node disorders and prognostic value of nodal involvement in patients treated for a borderline ovarian tumor: an analysis of a series of 42 lymphadenectomies.
Camatte S; Morice P; Atallah D; Pautier P; Lhommé C; Haie-Meder C; Duvillard P; Castaigne D
J Am Coll Surg; 2002 Sep; 195(3):332-8. PubMed ID: 12229940
[TBL] [Abstract][Full Text] [Related]
16. Lymph node involvement in ovarian serous tumors of low malignant potential: a clinicopathologic study of thirty-six cases.
Djordjevic B; Malpica A
Am J Surg Pathol; 2010 Jan; 34(1):1-9. PubMed ID: 19898226
[TBL] [Abstract][Full Text] [Related]
17. Nodal endosalpingiosis in ovarian serous tumors of low malignant potential with lymph node involvement: a case for a precursor lesion.
Djordjevic B; Clement-Kruzel S; Atkinson NE; Malpica A
Am J Surg Pathol; 2010 Oct; 34(10):1442-8. PubMed ID: 20871218
[TBL] [Abstract][Full Text] [Related]
18. International Federation of gynecology and obstetrics staging classification for cancer of the ovary, fallopian tube, and peritoneum: estimation of survival in patients with node-positive epithelial ovarian cancer.
Pereira A; Pérez-Medina T; Magrina JF; Magtibay PM; Rodríguez-Tapia A; Peregrin I; Mendizabal E; Ortiz-Quintana L
Int J Gynecol Cancer; 2015 Jan; 25(1):49-54. PubMed ID: 25405578
[TBL] [Abstract][Full Text] [Related]
19. Biological markers in pT1 and pT2 ovarian cancer with lymph node metastases.
Concin N; Hefler L; van Bavel J; Mueller-Holzner E; Zeimet A; Daxenbichler G; Speiser P; Hacker N; Marth C
Gynecol Oncol; 2003 Apr; 89(1):9-15. PubMed ID: 12694648
[TBL] [Abstract][Full Text] [Related]
20. Clinical Predictors of Recurrence and Prognostic Value of Lymph Node Involvement in the Serous Borderline Ovarian Tumor.
Qian XQ; Hua XP; Wu JH; Shen YM; Cheng XD; Wan XY
Int J Gynecol Cancer; 2018 Feb; 28(2):279-284. PubMed ID: 29194193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]